The tyrosine kinase inhibitor nilotinib is more efficient than mitotane in decreasing cell viability in spheroids prepared from adrenocortical carcinoma cells - Silveira, Elaine; Cavalcante, Isadora Pontes; Kremer, Jean Lucas; Mendonça, Pedro Omori Ribeiro de; Lotfi, Claudimara Ferini Pacicco (Cancer Cell International, 2018)